Journal of Antimicrobial Chemotherapy (2000) 45, 31-35
© 2000 The British Society for Antimicrobial Chemotherapy
Treatment of recurrent tonsillopharyngitis
Department of Clinical Bacteriology, Umeå University, S-90185 Umeå, Sweden
* Tel: +46-90-785-1120; Fax: +46-90-785-2225.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M.-I. Morosini, R. Canton, E. Loza, R. del Campo, F. Almaraz, and F. Baquero Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin J. Antimicrob. Chemother., July 1, 2003; 52(1): 50 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bronner, F. Jehl, J.-D. Peter, M.-C. Ploy, C. Renault, P. Arvis, H. Monteil, and G. Prevost Moxifloxacin Efficacy and Vitreous Penetration in a Rabbit Model of Staphylococcus aureus Endophthalmitis and Effect on Gene Expression of Leucotoxins and Virulence Regulator Factors Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1621 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
L D Liebowitz, M Slabbert, and A Huisamen National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents J. Clin. Pathol., May 1, 2003; 56(5): 344 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ince, X. Zhang, and D. C. Hooper Activity of and Resistance to Moxifloxacin in Staphylococcus aureus Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1410 - 1415. [Abstract] [Full Text] [PDF] |
||||


